Display options
Cite
Sadanandan N, Shear A, Brooks B, et al. Treating Metastatic Brain Cancers With Stem Cells. Front Mol Neurosci. 2021;14:749716doi: 10.3389/fnmol.2021.749716.
Sadanandan, N., Shear, A., Brooks, B., Saft, M., Cabantan, D. A. G., Kingsbury, C., Zhang, H., Anthony, S., Wang, Z. J., Salazar, F. E., Lezama Toledo, A. R., Rivera Monroy, G., Vega Gonzales-Portillo, J., Moscatello, A., Lee, J. Y., & Borlongan, C. V. (2021). Treating Metastatic Brain Cancers With Stem Cells. Frontiers in molecular neuroscience, 14749716. https://doi.org/10.3389/fnmol.2021.749716
Sadanandan, Nadia, et al. "Treating Metastatic Brain Cancers With Stem Cells." Frontiers in molecular neuroscience vol. 14 (2021): 749716. doi: https://doi.org/10.3389/fnmol.2021.749716
Sadanandan N, Shear A, Brooks B, Saft M, Cabantan DAG, Kingsbury C, Zhang H, Anthony S, Wang ZJ, Salazar FE, Lezama Toledo AR, Rivera Monroy G, Vega Gonzales-Portillo J, Moscatello A, Lee JY, Borlongan CV. Treating Metastatic Brain Cancers With Stem Cells. Front Mol Neurosci. 2021 Nov 24;14:749716. doi: 10.3389/fnmol.2021.749716. eCollection 2021. PMID: 34899179; PMCID: PMC8651876.
Copy Download .nbib Format: NLM
Share it on

Front Mol Neurosci. 2021 Nov 24;14:749716. doi: 10.3389/fnmol.2021.749716. eCollection 2021.

Treating Metastatic Brain Cancers With Stem Cells.

Frontiers in molecular neuroscience

Nadia Sadanandan, Alex Shear, Beverly Brooks, Madeline Saft, Dorothy Anne Galang Cabantan, Chase Kingsbury, Henry Zhang, Stefan Anthony, Zhen-Jie Wang, Felipe Esparza Salazar, Alma R Lezama Toledo, Germán Rivera Monroy, Joaquin Vega Gonzales-Portillo, Alexa Moscatello, Jea-Young Lee, Cesario V Borlongan

Affiliations

  1. Georgetown University, Washington, DC, United States.
  2. University of Florida, Gainesville, FL, United States.
  3. Department of Neurosurgery and Brain Repair, University of South Florida Morsani College of Medicine, Tampa, FL, United States.
  4. University of Michigan, Ann Arbor, MI, United States.
  5. Michigan State University College of Osteopathic Medicine, East Lansing, MI, United States.
  6. Lake Erie College of Osteopathic Medicine, Bradenton, FL, United States.
  7. Centro de Investigación en Ciencias de la Salud (CICSA), Facultad de Ciencias de la Salud (FCS), Universidad Anáhuac México Campus Norte, Huixquilucan, Mexico.
  8. Universidad Peruana de Ciencias Aplicadas, Lima, Peru.
  9. Center of Excellence for Aging and Brain Repair, University of South Florida Morsani College of Medicine, Tampa, FL, United States.

PMID: 34899179 PMCID: PMC8651876 DOI: 10.3389/fnmol.2021.749716

Abstract

Stem cell therapy may present an effective treatment for metastatic brain cancer and glioblastoma. Here we posit the critical role of a leaky blood-brain barrier (BBB) as a key element for the development of brain metastases, specifically melanoma. By reviewing the immunological and inflammatory responses associated with BBB damage secondary to tumoral activity, we identify the involvement of this pathological process in the growth and formation of metastatic brain cancers. Likewise, we evaluate the hypothesis of regenerating impaired endothelial cells of the BBB and alleviating the damaged neurovascular unit to attenuate brain metastasis, using the endothelial progenitor cell (EPC) phenotype of bone marrow-derived mesenchymal stem cells. Specifically, there is a need to evaluate the efficacy for stem cell therapy to repair disruptions in the BBB and reduce inflammation in the brain, thereby causing attenuation of metastatic brain cancers. To establish the viability of stem cell therapy for the prevention and treatment of metastatic brain tumors, it is crucial to demonstrate BBB repair through augmentation of vasculogenesis and angiogenesis. BBB disruption is strongly linked to metastatic melanoma, worsens neuroinflammation during metastasis, and negatively influences the prognosis of metastatic brain cancer. Using stem cell therapy to interrupt inflammation secondary to this leaky BBB represents a paradigm-shifting approach for brain cancer treatment. In this review article, we critically assess the advantages and disadvantages of using stem cell therapy for brain metastases and glioblastoma.

Copyright © 2021 Sadanandan, Shear, Brooks, Saft, Cabantan, Kingsbury, Zhang, Anthony, Wang, Salazar, Lezama Toledo, Rivera Monroy, Vega Gonzales-Portillo, Moscatello, Lee and Borlongan.

Keywords: blood brain barrier; bone marrow derived mesenchymal stem cell; brain metastases; endothelial progenitor cell; melanoma; neuroinflammation; stem cell therapy

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Cochrane Database Syst Rev. 2015 Oct 05;(10):CD006301 - PubMed
  2. Cancer. 2011 Jun 15;117(12):2719-27 - PubMed
  3. Nat Rev Mol Cell Biol. 2020 Feb;21(2):101-118 - PubMed
  4. Future Oncol. 2018 Dec;14(28):2957-2967 - PubMed
  5. Nat Rev Cancer. 2020 Jan;20(1):4-11 - PubMed
  6. Cancer Res. 2019 Sep 15;79(18):4557-4566 - PubMed
  7. Trends Neurosci. 2021 May;44(5):393-405 - PubMed
  8. Annu Rev Physiol. 2020 Feb 10;82:103-126 - PubMed
  9. J Cell Biol. 2008 Nov 3;183(3):409-17 - PubMed
  10. Neurosurgery. 2009 Jun;64(6):1139-46; discussion 1146-7 - PubMed
  11. Nat Rev Neurol. 2012 Dec;8(12):711-6 - PubMed
  12. Clin Cancer Res. 2007 Mar 15;13(6):1644-7 - PubMed
  13. Int J Med Sci. 2018 Jan 1;15(1):36-45 - PubMed
  14. IEEE Trans Biomed Eng. 2002 Feb;49(2):85-96 - PubMed
  15. Front Immunol. 2019 Jul 24;10:1713 - PubMed
  16. F1000Res. 2018 Nov 9;7: - PubMed
  17. Cancer Res Treat. 2019 Apr;51(2):797-811 - PubMed
  18. Blood. 2015 Aug 6;126(6):766-78 - PubMed
  19. J Clin Oncol. 2007 Jun 1;25(16):2306-12 - PubMed
  20. Exp Neurol. 2018 Dec;310:33-47 - PubMed
  21. Sci Rep. 2019 Mar 27;9(1):5280 - PubMed
  22. J Clin Med. 2019 Dec 29;9(1): - PubMed
  23. Stem Cells Transl Med. 2020 Jan;9(1):17-27 - PubMed
  24. Lancet Haematol. 2017 Nov;4(11):e510-e523 - PubMed
  25. Stem Cell Res Ther. 2015 Sep 29;6:187 - PubMed
  26. Cells. 2020 Feb 28;9(3): - PubMed
  27. BMB Rep. 2018 Jul;51(7):319-326 - PubMed
  28. Oncotarget. 2018 Jan 31;9(12):10621-10634 - PubMed
  29. Brain Res. 2004 Jun 4;1010(1-2):108-16 - PubMed
  30. Nat Rev Cancer. 2018 Nov;18(11):669-680 - PubMed
  31. Nat Rev Mol Cell Biol. 2004 Apr;5(4):261-70 - PubMed
  32. Nature. 2015 Nov 5;527(7576):100-104 - PubMed
  33. J Cereb Blood Flow Metab. 2013 Jul;33(7):1104-14 - PubMed
  34. Int J Nanomedicine. 2018 Oct 04;13:6049-6058 - PubMed
  35. N Engl J Med. 2006 Apr 27;354(17):1813-26 - PubMed
  36. Ann N Y Acad Sci. 2020 Feb;1462(1):27-36 - PubMed
  37. World J Clin Oncol. 2021 Sep 24;12(9):746-766 - PubMed
  38. Curr Stem Cell Res Ther. 2019;14(1):43-51 - PubMed
  39. Cell. 2009 Nov 13;139(4):693-706 - PubMed
  40. J Clin Oncol. 2011 Aug 20;29(24):3214-23 - PubMed
  41. Neural Regen Res. 2021 Apr;16(4):680-681 - PubMed
  42. Nature. 2010 Nov 25;468(7323):557-61 - PubMed
  43. Bioact Mater. 2020 Dec 26;6(7):1973-1987 - PubMed
  44. N Engl J Med. 2011 Jun 2;364(22):2119-27 - PubMed
  45. BMC Cancer. 2016 Jul 13;16:466 - PubMed
  46. Theranostics. 2020 May 15;10(14):6361-6371 - PubMed
  47. J Clin Oncol. 1997 May;15(5):1814-23 - PubMed
  48. Ann Neurol. 1991 Oct;30(4):581-8 - PubMed
  49. Adv Sci (Weinh). 2021 Feb 24;8(7):2002944 - PubMed
  50. Anticancer Res. 2020 Jun;40(6):3039-3047 - PubMed
  51. Curr Neuropharmacol. 2020;18(12):1227-1236 - PubMed
  52. Stem Cells Transl Med. 2021 Feb;10(2):251-266 - PubMed
  53. Int J Mol Sci. 2020 Jun 03;21(11): - PubMed
  54. Neuron. 1999 Jun;23(2):297-308 - PubMed
  55. Stem Cells Transl Med. 2013 Dec;2(12):983-92 - PubMed
  56. Cancer Res. 2016 Sep 1;76(17):4970-80 - PubMed
  57. Mech Dev. 2015 Nov;138 Pt 1:8-16 - PubMed
  58. Neoplasma. 2020 Mar;67(2):304-311 - PubMed
  59. Cerebrovasc Dis. 2012;33(5):492-9 - PubMed
  60. J Clin Invest. 2021 Mar 1;131(5): - PubMed
  61. Trends Cancer. 2016 Jun;2(6):295-304 - PubMed
  62. Ann Oncol. 2008 Jun;19(6):1082-9 - PubMed
  63. Mol Ther Oncolytics. 2016 Dec 14;4:67-76 - PubMed
  64. Hum Gene Ther. 1996 Mar 20;7(5):669-84 - PubMed
  65. Cancer Gene Ther. 2013 Dec;20(12):678-82 - PubMed
  66. Annu Rev Cell Dev Biol. 2019 Oct 6;35:591-613 - PubMed
  67. Sci Transl Med. 2015 Mar 4;7(277):277ra30 - PubMed
  68. Nat Med. 2017 Oct 6;23(10):1124-1134 - PubMed
  69. Cancer Metastasis Rev. 2010 Jun;29(2):285-93 - PubMed
  70. Nat Mater. 2018 Jul;17(7):642-651 - PubMed
  71. Exp Transl Stroke Med. 2013 Mar 14;5(1):4 - PubMed
  72. J Natl Cancer Inst. 1990 Jan 3;82(1):4-6 - PubMed
  73. Front Cell Dev Biol. 2020 Oct 30;8:587776 - PubMed
  74. Br J Cancer. 2011 Jul 26;105(3):353-9 - PubMed
  75. Mol Cell. 2013 Dec 12;52(5):693-706 - PubMed
  76. Adv Exp Med Biol. 2019;1136:71-85 - PubMed
  77. Cancer Lett. 2020 Oct 1;489:174-181 - PubMed
  78. Curr Neuropharmacol. 2020;18(12):1250-1265 - PubMed
  79. Stem Cell Res Ther. 2021 Mar 24;12(1):205 - PubMed
  80. Angiogenesis. 2017 May;20(2):185-204 - PubMed
  81. Cell Mol Neurobiol. 2013 May;33(4):489-501 - PubMed
  82. Cancer Immunol Immunother. 2019 Sep;68(9):1501-1513 - PubMed
  83. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3855-3864 - PubMed
  84. Science. 2005 Jan 7;307(5706):58-62 - PubMed
  85. Front Cell Neurosci. 2014 Dec 12;8:418 - PubMed
  86. Cancer Invest. 2002;20(3):293-302 - PubMed
  87. Crit Rev Eukaryot Gene Expr. 2019;29(4):343-350 - PubMed
  88. Neuromolecular Med. 2020 Dec;22(4):503-516 - PubMed
  89. Oncol Lett. 2016 Mar;11(3):1615-1620 - PubMed
  90. Lancet. 2018 Sep 15;392(10151):971-984 - PubMed
  91. Oncotarget. 2017 Jun 13;8(24):39522-39533 - PubMed
  92. Proc Natl Acad Sci U S A. 2019 Jul 9;116(28):14270-14279 - PubMed
  93. J Neurosci Res. 2019 Feb;97(2):137-148 - PubMed
  94. Int J Mol Sci. 2019 Aug 01;20(15): - PubMed
  95. CNS Neurosci Ther. 2021 Jan;27(1):36-47 - PubMed
  96. Theranostics. 2018 Feb 5;8(6):1481-1493 - PubMed
  97. Glia. 2004 Mar;45(4):325-37 - PubMed
  98. Biomed Res Int. 2015;2015:320941 - PubMed
  99. J Clin Neurosci. 2019 Feb;60:112-116 - PubMed
  100. Carcinogenesis. 2010 Jan;31(1):37-49 - PubMed
  101. Bone Marrow Transplant. 2003 May;31(9):755-61 - PubMed
  102. Int J Mol Sci. 2020 Nov 07;21(21): - PubMed
  103. Cancer Cell. 2019 Oct 14;36(4):418-430.e6 - PubMed
  104. Cell Transplant. 2015;24(4):625-30 - PubMed
  105. J Clin Invest. 2007 Dec;117(12):3988-4002 - PubMed
  106. Cells. 2020 Sep 11;9(9): - PubMed
  107. FEBS J. 2009 Sep;276(17):4622-35 - PubMed
  108. Science. 2020 Dec 11;370(6522):1328-1334 - PubMed
  109. Am J Clin Oncol. 2021 Aug 1;44(8):423-428 - PubMed
  110. Cochrane Database Syst Rev. 2016 May 20;(5):CD003139 - PubMed
  111. Nat Rev Neurosci. 2006 Jan;7(1):41-53 - PubMed
  112. CA Cancer J Clin. 2020 Mar;70(2):78-85 - PubMed
  113. J Clin Oncol. 2020 Aug 10;38(23):2610-2619 - PubMed
  114. Int J Mol Sci. 2018 Sep 22;19(10): - PubMed
  115. Cold Spring Harb Perspect Biol. 2015 Jan 05;7(1):a020412 - PubMed
  116. Crit Rev Oncol Hematol. 2018 Mar;123:95-113 - PubMed
  117. Trends Cancer. 2018 Mar;4(3):176-196 - PubMed
  118. Semin Cancer Biol. 2020 Feb;60:262-273 - PubMed
  119. Fluids Barriers CNS. 2019 Jul 1;16(1):18 - PubMed
  120. Acta Neuropathol Commun. 2021 Aug 23;9(1):142 - PubMed
  121. Crit Care Med. 2020 Apr;48(4):e290-e298 - PubMed
  122. Cancer Res. 2002 Jul 1;62(13):3603-8 - PubMed
  123. Nat Rev Clin Oncol. 2009 Jul;6(7):395-404 - PubMed
  124. J Clin Oncol. 1992 Oct;10(10):1615-23 - PubMed
  125. Nature. 2020 Jan;577(7788):115-120 - PubMed
  126. Int J Med Sci. 2020 Feb 18;17(5):609-619 - PubMed
  127. Cell Mol Life Sci. 2021 Mar;78(5):1853-1860 - PubMed
  128. Mol Cancer. 2019 Mar 30;18(1):60 - PubMed
  129. Mol Cell. 2012 Aug 24;47(4):570-84 - PubMed
  130. Antioxid Redox Signal. 2020 Feb 10;32(5):285-308 - PubMed
  131. Cell Mol Biol Lett. 2019 Jun 17;24:43 - PubMed
  132. J Exp Med. 2020 Apr 6;217(4): - PubMed
  133. Nat Rev Cancer. 2020 Jan;20(1):26-41 - PubMed
  134. Cancer Lett. 2011 Dec 8;311(2):152-9 - PubMed
  135. Oncotarget. 2016 Dec 6;7(49):80521-80542 - PubMed
  136. Angiogenesis. 2019 Feb;22(1):15-36 - PubMed
  137. Physiol Rev. 2019 Jan 1;99(1):21-78 - PubMed
  138. Cancers (Basel). 2020 Dec 11;12(12): - PubMed
  139. Int J Nanomedicine. 2019 Jul 29;14:5925-5942 - PubMed
  140. Clin Cancer Res. 2016 Dec 15;22(24):6078-6087 - PubMed
  141. Melanoma Res. 2011 Aug;21(4):357-63 - PubMed
  142. Stem Cell Res Ther. 2018 Aug 24;9(1):228 - PubMed
  143. Stem Cells Int. 2020 Jul 10;2020:8842659 - PubMed
  144. Pharmacol Res. 2019 Sep;147:104349 - PubMed
  145. J Stroke Cerebrovasc Dis. 2020 May;29(5):104748 - PubMed
  146. Br J Neurosurg. 2001 Apr;15(2):101-8 - PubMed
  147. Acta Neuropathol. 2000 Sep;100(3):323-31 - PubMed
  148. N Engl J Med. 2000 Apr 13;342(15):1069-76 - PubMed
  149. Oncology. 2011;80(3-4):181-7 - PubMed
  150. Br J Dermatol. 2017 Jul;177(1):134-140 - PubMed
  151. J Biomed Sci. 2018 Mar 6;25(1):20 - PubMed
  152. Histol Histopathol. 1994 Oct;9(4):807-43 - PubMed
  153. J Clin Oncol. 1989 Jul;7(7):916-22 - PubMed
  154. J Cereb Blood Flow Metab. 2020 Jun;40(6):1167-1171 - PubMed
  155. Oncol Lett. 2016 Feb;11(2):1089-1094 - PubMed
  156. Cancer. 1986 Aug 15;58(4):832-9 - PubMed
  157. Adv Cancer Res. 2020;148:1-26 - PubMed
  158. Cell Mol Life Sci. 2020 May;77(9):1745-1770 - PubMed
  159. Clin Cancer Res. 2001 Jun;7(6):1582-9 - PubMed
  160. J Immunother Cancer. 2019 Jul 30;7(1):200 - PubMed
  161. JAMA Oncol. 2020 Apr 1;6(4):528-534 - PubMed
  162. Adv Exp Med Biol. 2020;1263:85-115 - PubMed
  163. Curr Opin Neurobiol. 2019 Aug;57:32-38 - PubMed
  164. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003142 - PubMed
  165. Oncology. 2000 Nov;59(4):291-5 - PubMed
  166. Stem Cells Int. 2020 Aug 11;2020:8837654 - PubMed
  167. Clin Cancer Res. 2011 Apr 1;17(7):1875-82 - PubMed
  168. Nat Commun. 2014 Jun 19;5:4196 - PubMed
  169. Nat Biomed Eng. 2018 Nov;2(11):831-840 - PubMed
  170. Cell. 2018 Aug 9;174(4):843-855.e19 - PubMed
  171. World J Gastroenterol. 2019 Feb 7;25(5):567-583 - PubMed
  172. Adv Exp Med Biol. 2018;1092:91-112 - PubMed
  173. J Control Release. 2015 Nov 10;217:113-20 - PubMed
  174. Clin Cancer Res. 2007 Mar 15;13(6):1663-74 - PubMed
  175. Angiogenesis. 2020 May;23(2):159-177 - PubMed
  176. J Cell Mol Med. 2020 Jan;24(1):530-538 - PubMed
  177. Cancer Treat Rev. 2020 Apr;85:101975 - PubMed
  178. J Cereb Blood Flow Metab. 2011 Feb;31(2):693-705 - PubMed
  179. Int J Nanomedicine. 2019 Apr 23;14:2847-2859 - PubMed
  180. Clin Exp Metastasis. 2018 Aug;35(5-6):379-391 - PubMed
  181. Nat Rev Cancer. 2013 Apr;13(4):258-71 - PubMed
  182. Cancer Lett. 2019 Jan;440-441:47-53 - PubMed
  183. Biol Blood Marrow Transplant. 2012 Aug;18(8):1273-80 - PubMed
  184. J Hematol Oncol. 2021 Feb 12;14(1):24 - PubMed
  185. Sci Transl Med. 2012 Nov 21;4(161):161ra150 - PubMed
  186. Nature. 2016 May 18;533(7604):493-498 - PubMed
  187. Clin Cancer Res. 2007 Mar 15;13(6):1656-62 - PubMed
  188. Angiogenesis. 2021 Feb;24(1):35-46 - PubMed
  189. Adv Exp Med Biol. 2020;1234:31-42 - PubMed
  190. Cold Spring Harb Perspect Biol. 2012 Feb 01;4(2): - PubMed
  191. Curr Pharm Des. 2020;26(13):1417-1427 - PubMed
  192. Cells. 2020 Aug 13;9(8): - PubMed
  193. Eur J Cancer. 1997 Dec;33(14):2368-75 - PubMed
  194. Cancer Res. 1998 Apr 1;58(7):1408-16 - PubMed
  195. Clin Cancer Res. 2019 Sep 15;25(18):5449-5457 - PubMed
  196. Acta Neuropathol. 2018 Mar;135(3):311-336 - PubMed
  197. J Neuroimmune Pharmacol. 2006 Sep;1(3):223-36 - PubMed
  198. Brain Res. 2019 Dec 1;1724:146428 - PubMed
  199. Nat Med. 2018 Sep;24(9):1481 - PubMed
  200. Transl Oncol. 2021 Jan;14(1):100948 - PubMed
  201. Front Immunol. 2020 Nov 06;11:578879 - PubMed
  202. Int J Mol Sci. 2020 Nov 07;21(21): - PubMed
  203. Cell Oncol (Dordr). 2019 Oct;42(5):591-608 - PubMed
  204. J Clin Oncol. 2007 Jan 20;25(3):247-56 - PubMed
  205. Nat Ecol Evol. 2017 Aug;1(8):1051-1052 - PubMed
  206. Stem Cells Dev. 2012 Sep 1;21(13):2355-63 - PubMed
  207. Trends Cancer. 2019 Aug;5(8):495-505 - PubMed
  208. Brain Behav Immun. 2017 Feb;60:220-232 - PubMed
  209. Pharmaceutics. 2021 Mar 18;13(3): - PubMed
  210. Cancer Treat Rev. 2020 Sep;89:102083 - PubMed
  211. Cancer Treat Rev. 2019 Nov;80:101896 - PubMed
  212. J Neuroinflammation. 2019 Jan 5;16(1):2 - PubMed
  213. J Control Release. 2014 Oct 28;192:262-70 - PubMed
  214. Lancet Haematol. 2016 Aug;3(8):e388-97 - PubMed
  215. Bone Marrow Transplant. 1994 Apr;13(4):449-54 - PubMed
  216. Stem Cells. 1996 Jan;14(1):79-89 - PubMed
  217. Stem Cells. 2017 May;35(5):1246-1258 - PubMed
  218. Int J Clin Exp Pathol. 2015 May 01;8(5):4715-24 - PubMed
  219. Cancer. 1994 Mar 15;73(6):1678-85 - PubMed
  220. Neuro Oncol. 2018 Jan 22;20(2):184-191 - PubMed
  221. Nature. 2010 Nov 25;468(7323):562-6 - PubMed
  222. Cytotherapy. 2021 Mar;23(3):223-235 - PubMed
  223. Neurobiol Dis. 2018 Jun;114:95-110 - PubMed
  224. Crit Rev Oncol Hematol. 2002 Feb;41(2):241-50 - PubMed
  225. Int J Radiat Biol. 2019 Jul;95(7):912-919 - PubMed
  226. Acta Pharm Sin B. 2020 Jun;10(6):987-1003 - PubMed
  227. Oncogene. 2014 May 22;33(21):2768-78 - PubMed
  228. Cancer Res. 2017 May 1;77(9):2266-2278 - PubMed
  229. Stem Cell Res Ther. 2019 Jul 29;10(1):224 - PubMed
  230. Eur J Cancer. 2002 Sep;38(13):1724-9 - PubMed
  231. Nat Cell Biol. 2014 Sep;16(9):876-88 - PubMed
  232. Semin Cancer Biol. 2011 Apr;21(2):107-12 - PubMed
  233. Cell Transplant. 2011;20(6):789-95 - PubMed
  234. Mol Cells. 2010 Aug;30(2):93-8 - PubMed
  235. Dev Cell. 2012 Feb 14;22(2):403-17 - PubMed
  236. Brain Behav Immun. 2017 Feb;60:1-12 - PubMed
  237. Cell Death Dis. 2018 Jan 25;9(2):115 - PubMed
  238. Expert Opin Biol Ther. 2016 Sep;16(9):1079-92 - PubMed
  239. Curr Oncol Rep. 2018 Nov 9;20(11):91 - PubMed
  240. J Control Release. 2021 Jan 10;329:934-947 - PubMed

Publication Types